Line 360: | Line 360: | ||
<br> | <br> | ||
− | Micronutrient deficiencies plague impoverished and developing nations throughout the world. According to the World Health Organization (WHO), over 2 billion people - representing more than 30% of the world’s population - suffer from micronutrient deficiencies. However, diagnosis of micronutrient deficiency has proven to be extremely expensive and oftentimes time-consuming. To address this growing concern, medical professionals and synthetic biologists have created simple, inexpensive “biosensors” that serve as handy diagnostic tests to use in the field. Nevertheless, these versatile tools still suffer many errors that often yield inaccurate results and even lead to faulty diagnosis. With this in mind, the 2016 Lambert iGEM Team focused primarily on how to enhance existing biosensors and subsequently aid in the diagnosis of micronutrient deficiencies throughout the world. | + | <p style="width: 100%; margin: auto; font-size: 16px;"> Micronutrient deficiencies plague impoverished and developing nations throughout the world. According to the World Health Organization (WHO), over 2 billion people - representing more than 30% of the world’s population - suffer from micronutrient deficiencies. However, diagnosis of micronutrient deficiency has proven to be extremely expensive and oftentimes time-consuming. To address this growing concern, medical professionals and synthetic biologists have created simple, inexpensive “biosensors” that serve as handy diagnostic tests to use in the field. Nevertheless, these versatile tools still suffer many errors that often yield inaccurate results and even lead to faulty diagnosis. With this in mind, the 2016 Lambert iGEM Team focused primarily on how to enhance existing biosensors and subsequently aid in the diagnosis of micronutrient deficiencies throughout the world. |
<br><br> | <br><br> | ||
Revision as of 03:38, 19 October 2016
Integrated Practices
![](https://static.igem.org/mediawiki/2016/2/26/T--LambertGA--purpleline.jpg)
Micronutrient deficiencies plague impoverished and developing nations throughout the world. According to the World Health Organization (WHO), over 2 billion people - representing more than 30% of the world’s population - suffer from micronutrient deficiencies. However, diagnosis of micronutrient deficiency has proven to be extremely expensive and oftentimes time-consuming. To address this growing concern, medical professionals and synthetic biologists have created simple, inexpensive “biosensors” that serve as handy diagnostic tests to use in the field. Nevertheless, these versatile tools still suffer many errors that often yield inaccurate results and even lead to faulty diagnosis. With this in mind, the 2016 Lambert iGEM Team focused primarily on how to enhance existing biosensors and subsequently aid in the diagnosis of micronutrient deficiencies throughout the world.
The Styczynski Group at the Georgia Institute of Technology is working on developing a Zinc micronutrient biosensor. After collaborating with them at GT, we gained a better understanding of some of the problems that entail the development of biosensors. Often times, biosensors do not consistently yield accurate responses to specific signals because of severe leakiness that may exist in the system or fluctuations in the affinities of biosensing promoters used in the system. Moreover, the overexpression of one pigment (or GFP) over another can also cause misreadings. Such was the case with GT’s Zinc biosensor - the overexpression of the pigment Violacein over the other pigments caused the system to display the wrong color at the wrong time.
Consequently, we studied protein degradation and devised a “Switch” that attempts to prevent this sort of overexpression and subsequently fine tune the overall accuracy of biosensors in general. We used SsrA tagged reporters in an inducible plasmid construct to characterize the relative strength of degradation as well as learn more about the protease ClpXP. To further characterize ClpXP, we used three different strains of E. coli cells (DH10, Keio Wild ClpX Knockout, Keio Wild ClpP Knockout) from the ECSC Yale Keio registry. The Keio strains are specific E. coli strains that express distinct gene knockouts; we worked with the ClpP knockout (JWO428-1), ClpX Knockout (JWO427-1) and the Keio Wild strains. However, due to time constraints, we were only able to grow and gain results for the ClpP strain.
Given the physical and financial constraints of a high school laboratory, we didn’t have the luxury of using a fluorometer to quantify the relative strength of degradation in GFP molecules. Therefore, we used chromoproteins because they were visible to the naked eye. We exploited the chromoproteins’ stark visibility and constructed the ChromQ - a 3D printed “camera system” that feasibly quantifies the chromoproteins in a light-controlled chamber. After taking pictures of the chromoproteins inside the ChromQ light-chamber, we converted the pixels from the pictures into RGB values by using a commercial photo-editing software. In order to standardize chromoprotein expression, we used Roscolux filters to create a color chart that correlates with each degree of degradation in chromoproteins.
To deliver a more immediate impact outside the lab, we collaborated with numerous institutions to increase awareness of micronutrient deficiencies and synthetic biology in general. For example, we partnered with the Atlanta Science Festival to hold a discussion about the merits of GMOs. The discussion was lead by a team of professors from the University of Georgia, Emory University, Georgia Institute of Technology, and Georgia State University. Titled “GMOs or GMnos”, the discussion was held at GT and received over 100 participants. Moreover, we also hosted a workshop at the Building with Biology event at the Atlanta Maker Faire. We used this event as a venue to educate the public about DNA extraction and the recently discovered CRISPR-Cas9 gene editing technology. We even collaborated with Next Generation Focus, a non-profit organization based in Forsyth County, to educate underprivileged students in Forsyth County about synthetic biology and biotechnology.
All in all, from devising an inducible plasmid construct in order to fine tune existing biosensors and further characterize a known protease system to collaborating with various universities and nonprofit organizations, the 2016 Lambert iGEM Team has delivered an impact both inside and outside the scientific community.